On the same basis, a genome-wide association study (GWAS) identified various genetic variants, such as the serotonin transporter, BDNF, and interleukin-11 gene, associated with differential treatment responses, further highlighting the potential of genetic markers in the treatment of anxiety disorders [71]. This evidence concerns the gene BDNF and anxiety disorder.